2023-11-10 00:43:51
According to the FDA, at least five million cases of infection have been recorded over the past 15 years.
Read also: When mosquitoes help fight diseases
“Chikungunya virus infections can lead to serious and long-term health problems, particularly for the elderly and individuals with a medical history,” Peter Marks, a senior official at the American agency, said in the press release. .
Two clinical trials conducted
The vaccine is injected in one dose, and contains the attenuated virus – a standard technique used for other vaccines.
Two clinical trials were carried out in North America on several thousand people. The main side effects are headaches, fatigue, muscle pain, and even nausea. In rare cases, more serious reactions have been noted, the FDA said. Two clinical trial participants who received the vaccine required hospitalization.
An application for authorization has also been filed by Valneva with the European Medicines Agency (EMA).
1699581621
#approves #chikungunya #vaccine